#CNSY Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests

https://www.stocktitan.net/news/CNSY/cerenome-secures-in-network-agreement-with-florida-blue-for-cn-side-3rq7klrwvzy1.html?utm_source=stocktitan-bluesky&utm_medium=social

#CNSY Cerenome Launches CNSide® CSF Molecular Profile Tests

https://www.stocktitan.net/news/CNSY/cerenome-launches-cn-side-csf-molecular-profile-8ub9s7nfreh9.html?utm_source=stocktitan-bluesky&utm_medium=social

#CNSY Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings

https://www.stocktitan.net/news/CNSY/cerenome-expects-1-55-million-in-cn-side-third-quarter-gross-assxt9d54qt0.html?utm_source=stocktitan-bluesky&utm_medium=social

#CNSY Cerenome to Hold CNSide® Business Update Call on September 30, 2026

https://www.stocktitan.net/news/CNSY/cerenome-to-hold-cn-side-business-update-call-on-september-30-ddbel2wzof4n.html?utm_source=stocktitan-bluesky&utm_medium=social

#CNSY Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

https://www.stocktitan.net/news/CNSY/cerenome-appoints-samantha-fowlkes-as-vice-president-and-head-of-6y1j9fzgn9f6.html?utm_source=stocktitan-bluesky&utm_medium=social

#CNSY #PSTV Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment

https://www.stocktitan.net/news/CNSY/cerenome-announces-up-to-20-million-financing-facility-with-royalty-dply9kcxoylr.html?utm_source=stocktitan-bluesky&utm_medium=social